---

September 19, 2018

Neopharma participated as an exhibitor in the 1st edition of CPHI Middle East & Africa, held at the ADNEC Center, Abu Dhabi, United Arab Emirates from 3rd to 5th September, 2018.

CPHI Middle East & Africa has emerged after rebranding and relocation of CPHI Istanbul focused on pharmaceutical industry in the MENA region. The pharma market in the MENA (Middle East and North Africa) economies are a mixture of developed, high-income healthcare systems, coupled with high growth regions in North Africa. Total pharma sales are an impressive $32bn – with a compound annual growth rate of 7% predicted through to 2020. CPHI, known as the world’s leading pharmaceutical networking event, promotes business partnerships and innovation in the pharmaceutical industry and provides a platform for professionals to explore the latest information in this field.

Neopharma participated in the 3-day event for to showcase its global presence, latest manufacturing facilities and newly formed API manufacturing division. Neopharma’s participation in the exhibition has provided the company with a wide access to pharmaceutical insights, potential collaborations along with latest industry updates in the MENA region.